Steven Cohen Edwards Lifesciences Corp Call Options Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $4.35 Million - $5.73 Million	60,000 Added 312.5%	79,200 $7.57 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $1.32 Million - $1.77 Million	19,000 Added 9500.0%	19,200 $1.33 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $16,282 - $18,866	200 New	200 $18,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $4.25 Million - $5.13 Million	-100,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $6.7 Million - $8.55 Million	-180,100 Reduced 64.3%	100,000 $14 Million

Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $9.46 Million - $11 Million	280,100	280,100 $31.6 Million

1,375

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.